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NMDAR
• Stands for “N-Methyl-D-Aspartate
Receptor”, which a is a synaptic
receptor believed to be present in
>90% of synaptic junctions
• However, the receptor accepts
glutamate (a key excitatory
neurotransmitter) and glycine as
its ligands
• Activating the NMDA receptor
leads to an inhibitory effect

NMDAR Immunity
• Despite its necessity, antibodies that downregulate the receptor can
be developed, leading to higher levels of brain stimulation and
excitement
• The body can present subunits for the protein (such as NR1) as
antigens and thus develop specific immunity to the protein
• This effect is particularly common in the case of HSV infection, as
observed by Dr. Pruss et al’s research team

HSV – Herpes Simplex Virus
• Inflammatory response tends not to arise from the brain
• However, infection can occur when viral and bacterial
antigens infiltrate the blood-brain barrier (especially prions)
• Microglia (phagocytes within the central nervous system)
are typically responsible for eliminating antigens in the CNS,
but their relative number is low
• Furthermore, HSV-1 (the variant used within the study) has
been shown to be particularly infectious
• ”[In 2016], an estimated 3752.0 million people had HSV type 1
infection at any site, equivalent to a global prevalence of 66.6% in
0-49 year olds” (James et al.)”

HSE – Herpes Simplex Encephalitis
• Despite the prevalence of HSV type 1, the encephalitis form is quite uncommon
as it requires the centralization of the virus within the brain as opposed to more
susceptible areas such as the eyes and nose (1 in 500,000 persons per year)
• The infection leads to an inflammatory response within the brain, leading to the
accumulation of CSF (cerebral spinal fluid) and serum around the infected area
• In comparison with other infections that transmit themselves throughout the
body, the brain blood supply is relatively isolated in the brain

HSE - Herpes Simplex Encephalitis
• Due to the lack of immune support within the
brain, the symptoms of HSE remain for extended
periods of time
• What is encephalitis?
• The inflammatory response induced by the viral
infection
• The inflammation leads to swelling, causing the brain
to press against the meninges and skull
• Patients with encephalitis usually complain of
headache, mild-flu like symptoms, and neck stiffness

What is used to treat HSE?
• Acyclovir, an antiviral, is commonly prescribed to treat HSV1
• Pharmacy names: Sitavig, Zovirax

A secondary immune response?
• It was observed that HSE patients who were immunocompetent had
more severe symptoms that patients who were immunocompromised
• In essence, the younger individuals tended to be worse off than older
patients with HSE
• This finding suggests the presence of a secondary immune response –
an immune response targeted at something that is NOT the virus (an
autoimmune response)
• This hypothesis is in line with improved outcomes “when combining
acyclovir with corticosteroids”
• Corticosteroids suppress an immune response

Immunity against NMDAR
• When you add immunity against NMDAR, neurons are attacked
because of two mechanisms as opposed to one:

• 1. viral cytotoxicity
• 2. detection of NMDA surface receptor (become the target of a specific
immune response)

• HSE usually develops in the hippocampus, leading to cognitive
(memory) and limbic (behavioral, emotional) deficits
• These symptoms are easily detected by family members, but they are
difficult to identify on the part of the patients
• “Interestingly, we detected significantly longer intervals between the first
prodromal symptoms and hospital admission in patients with NMDAR
antibodies.”

Experimental Methods
• “we performed a blinded retrospective study analyzing a large
archived cohort of consecutive serum and cerebrospinal fluid (CSF)
samples from patients with a definite diagnosis of HSE”
• The identities of the patients were masked from the experimenters
• The experimenters extracted only the CSF and serum of these patients, as
these locations are where you can observe an immune response (test for
antibody concentration, median white blood cell count, protein
concentration)
• All 44 patients studied were diagnosed with HSE as proved by PCR techniques

• Going forward: HSE ≠ anti-NMDAR encephalitis

Patients
• All patients had presented three common characteristics:
• Diagnosed with HSE in accordance with the German Society of
Neurology standards
• Had laboratory and imaging findings
• Received IV acyclovir treatments for at least 2 weeks

• Control patients (“Entero”)
• 10 patients with enterovirus encephalitis
• 10 patients with varicella zoster virus
• Both of these viruses are related to herpes simplex virus

• Informed consent was taken retrospectively

Testing for Antibodies
• Method: recombinant immunofluorescence
• Plasmids encoding for NMDAR were introduced to
HEK293 cells (human embryonic kidney cells) and
these cells were grown on slides
• Fragments from the slides were cut and put
alongside rat hippocampus and cerebellum cells
• Finally, these samples were introduced to CSF and
serum samples from the patients and incubated at
room temperature

Testing for Antibodies
• After incubation, the samples
were treated with fluoresceinconjugated goat-anti-human IgG,
IgA, or IgM antibodies for 30 min
• These antibodies, independent of
the antibodies from the patient
serum or CSF, would target the
NMDARs

• The samples were then washed
with PBS

Testing for Antibodies
• The prevalence of antibodies could be
determined based on the illumination of
the antibody stains
• If the stains were sufficiently bright, the
patient was considered immuno-positive
toward anti-NMDAR antibodies
• When the antibody for NMDAR index was
>4 for an Ig class prior to dilution, there
was evidence of NMDAR-specific
immunity for that Ig class (immunopositive result)
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Testing for Antibodies – Results

• A: Immunity to NMDA receptors observed for IgM
• B + C: No immunity to NMDA receptors observed for IgA and IgG
• D - F: In IgM immunopositively samples, the stains from recombinant immunofluorescence from the patient
antibodies and the goat antibodies are shown individually, as well as merged

Obtaining mouse hippocampus cultures

•
•
•
•

Cells from the mouse hippocampus were first obtain from a lab
Cells were then applied to a growth solution (“fetal calf serum”, ...)
Cells were then spun in a centrifuge
Cells were then resuspended (mixed in, usually after centrifugation), into another serum containing a mix of
chemicals usually present within the cellular space of neurons

Western Blot of Mouse Hippocampus Cells
Sample
Preparation
Goal: isolate
antibodies
from a protein
cocktail

•At day 10, neurons were
isolated and resuspended
in cytotoxic factors, and
spun in a centrifuge.

Gel
Electrophoresis

•Remaining solution was
added to a stacking gel,
and a current was applied
causing the proteins to
separate based on
molecular size measured
in kD

Protein
Transfer

•The separating gel is placed
between membranes that
acquire the proteins and
enable antibody detection
through placement in an
electric field. Membrane was
resolved in “nitrocellulose
membranes”

Western Blot of Mouse Hippocampus Cells

Goal: isolate
antibodies
from a protein
cocktail

Blocking &
Antibody
Application

• Antibodies specific to the
protein, protein subunit,
or peptide of interest (in
this case, the NR1 subunit)
is introduced to the
membrane in such a way
that they do not bind nonspecifically.

Observation
& Indexing

• The antibodies are brought
to illuminate. Based on the
intensity of the light, the
density of the protein can be
assessed. The presence of
luminescence also means
that the protein of interest is
present. The

Western Blot of Mouse Hippocampus Cells –
Results

• Actin (control): no observed downregulation as no antibodies against actin were created as they had HSE
• NMDAR – NR1 subunit: In the patient serum, the presence of the NR1 subunit of NMDAR is lower than when
no patient serum or CSF was added
• Thus, the patient antibodies lead to deterioration of NMDAR

Immunocytochemistry
• The researchers are also able to quantify the downregulation of
NMDARs by staining the plates and comparing the presence of
NMDAR for plates treated with patient serum/CSF and compare it to
a control
• Anti-synapsin antibody was used for staining (does not downregulate
NMDAR on its own – is just a staining technique)
• After three days of exposure to the patient serum, the fluorescence of
each sample was observed
• However, without converting to grayscale, a complex image is derived
and cannot be assessed quantitatively

Immunocytochemistry – Results

• On day 1, the presence of the red dots would be virtually the same
• However, after three days, the red dots have reduced in number, suggested a decline in the amount of NMDAR
due to the presence of anti-NMDAR antibodies in the patient serum/CSF
• In grayscale, the brightness of the surrounding anti-synapsin antibodies is significantly lower in the patient
serum, suggesting once again that NMDAR antibodies was downregulated

General Results
• In 13/44 patients, an immuno-positive result was
observed
• Breakdown by Ig class:
• IgA: 9
• IgG: 5
• IgM: 9

• Recombinant immunofluorescence confirmed the
presence of NMDAR antibodies
• Furthermore, the Western Blot and
immunocytochemistry procedures quantified the
downregulation (decline) in the amount of NMDAR
present in the mouse hippocampus cells after being
exposed to the patient serum

General Results
• In 2 of the patients, they demonstrated immunity against both the
NR1 and NR2 subunits of NMDAR
• Antibodies against cancer or other diseases were not detected,
suggesting a strong correlation between HSE and the development of
the anti-NMDAR antibodies
• Even when the researchers lowered the initial concentrations of the
CSF and serum, 11/44 tests com out as immuno-positive (25%) and
lead to the downregulation of NMDAR
• IgM wasfound to downregulate NMDAR at a similar level to IgA and
IgG (novel insight)

General Results
• In some patients, antibody titers for NMDAR were found in days 4-9
after diagnosis, suggesting that antibodies against NMDAR did not
come about because of infection with HSV
• Hypothesis: HSE symptoms were difficult to detect, and the antibodies began
to develop after the onset of HSV instead of the point of diagnosis

• However, when treated with acyclovir, clinical symptoms reduced,
and immunity toward NMDAR dropped
• After clinically presenting with HSE, patients largely experienced the
same symptoms at the same intensities whether they were immunopositive to NMDAR or not

General Results
• The presence of NMDAR antibodies did not lead to poorer
symptoms?
• The downregulation of NMDAR did not lead to worse cognition or pain
• Undermines the usefulness of NMDAR in the nervous system

• However, being antibody-positive toward NMDAR did lead to a delay
for clinical presentation
• However, the “clinical course of patients was not different”
• Downregulation of NMDAR was only observed in patients with IgG
antibodies

Novel Insights
• IgG led to the worst effects in terms of
the downregulation of NMDAR despite
only playing an autoimmune role in 4/44
patients
• However, IgM also caused loss of NMDAR
from the cell-membrane and a lower
expression of synapsin (a general marker
for synaptic receptors), similar to the
previously-observed effects of IgG against
NMDAR in other studies
• Thus, immunoglobulin of all classes play a
role in NMDA-related encephalitis

Conclusions
• At a rate of at least 25%, NDMAR antibodies were present in patients
presenting with HSE and led to the downregulation of NMDAR
• Thus, physicians must way the potential effects of HSE on a macroscale
(pressure from the skull) as well as a microlevel (lower expression of
synaptic proteins)
• So, infection with HSV leading to encephalitis leads to autoimmunity to
NMDAR
•
•
•
•

How?
Perhaps those 25% of HSE patients are presenting with anti-NMDAR encephalitis
Unlikely, given the low prevalence of both disease
There must be a causal factor

Conclusions
• Hypothesis: After cell lysis due to viral destruction,
cellular membranes are presented to immune cells in
the brain as antigens, leading to an autoimmune
response
• Another hypothesis: The CNS inflammation in HSE
patients caused an immune response and led to the
identification of multiple antigens for a specific immune
response, leading to the crossover between HSE and
anti-NMDAR encephalitis
• Discussion Question: Which hypothesis serves as a
more reliable reason for the autoimmune response to
NMDAR?

Further Conclusions
• Despite the lack of more complicated clinical symptoms until the end
of HSE treatment, NMDAR immunity does not bode well long-term
• Has been linked to choreoathetosis in patients (jerky moments due to lack of
inhibition in neurons) 1 month into treatment
• However, this finding may be a side effect of acyclovir
• Following treatment, seizures arise

• No long-term follow-up was conducted, preventing the study of
continued NMDAR immunity

Clinical Implications
• Patients with HSE should be tested for NMDAR immunity
• Long-term follow-ups with patients immuno-positive for NMDAR after
coming out of HSE should be conducted
• Additional screening on patients with IgA and IgM antibodies should
be conducted since these antibodies were more frequent than IgG
antibodies
• Patients with HSE and anti-NMDAR encephalitis may benefit from
immunotherapy (ex: acyclovir)

Discussion Questions
• Should anti-NMDAR immunity treatments be a
concern for researchers given the prevalence of other
life-changing disorders such as diabetes and cancer?
• Would you expect HSV-1 immunity due to a vaccine
to lead to lower levels of anti-NMDAR immunity?
• Technological tools allowed the researchers to
observe the staining of the neurons at a cellular level
and convert the synapsin-stained slides into grayscale
images. Should we place a greater emphasis on
technology instead of fundamental research?
• The antibody index of 4 is arbitrary (unless
established from previous research). Should we rely
on more quantitative means for research instead of
trying to visualize the data qualitatively (ex: by using
staining techniques)?
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